NanoVibronix effects 1-for-10 reverse stock split effective Aug 11, 2025

ENvue Medical, Inc.

Reverse stock split reduces outstanding shares from 7,968,868 to ~796,887.
Effective 4:05 p.m. ET on Aug 11, 2025; split-adjusted trading begins Aug 12, 2025.
No fractional shares issued; any fractional shares rounded up to whole number.
Adjustments made to equity awards, warrants, and convertible securities proportionally.
New CUSIP 63008J884; trading symbol remains NAOV on Nasdaq Capital Market.

item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ENvue Medical, Inc.: 1-for-10 reverse stock split of common stock (effective 2025-08-11).

Change: charter amendment
Effective: 2025-08-11

Exact text from the filing

filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-10 reverse stock split

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-022751

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.